Self reported sleep quality and cognitive performance in ecstasy users

Human Psychopharmacology

Volumn 22, Issue 8, 2007, Pages 537-548

  Montgomery, Catharine ^a   Fisk, John E ^b   Wareing, Michelle ^a   Murphy, Philip ^c  

^a LIVERPOOL JOHN MOORES UNIVERSITY   (United Kingdom)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

^c EDGE HILL UNIVERSITY   (United Kingdom)

Author keywords

Ecstasy; MDMA; Memory; Sleep

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; AMPHETAMINE; CANNABIS; COCAINE;

ADULT; ARITHMETIC; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; COVARIANCE; EPWORTH SLEEPINESS SCALE; FATIGUE; HUMAN; INTELLIGENCE; LEARNING; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SELF REPORT; SEMANTICS; SLEEP DISORDER; SUBSTANCE ABUSE; THINKING;

ADULT; AMPHETAMINE-RELATED DISORDERS; ATTENTION; COCAINE-RELATED DISORDERS; COGNITION; COMORBIDITY; FEMALE; HALLUCINOGENS; HUMANS; MALE; MARIJUANA ABUSE; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; SLEEP; WAKEFULNESS;

EID: 37849042791     PISSN: 08856222     EISSN: 10991077     Source Type: Journal    
DOI: 10.1002/hup.879     Document Type: Article

References (60)

1. Allen R, McCann UD, Ricaurte GA. 1993. Persistent effects of (+)3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on human sleep. Sleep 16(6): 560-564.
2. Baylen CA, Rosenberg H. 2006. A review of the acute subjective effects of MDMA/ecstasy. Addiction 101: 933-947.
3. Biello SM, Dafters RI. 2001. MDMA and fenfluramine alter the response of the circadian clock to a serotonin agonist in vitro. Brain Res 920: 202-209.
4. Chen NH, Johns MW, Li HY, et al. 2002. Validation of a Chinese version of the Epworth sleepiness scale. Qual Life Res 11: 817-821.
5. Colbron S, Jones M, Biello SM. 2002. MDMA alters the response of the circadian clock to a photic and non-photic stimulus. Brain Res 956: 45-52.
6. Cole JC, Sumnall HR. 2003. Altered states: the clinical effects of ecstasy. Pharmacology & Therapeutics 98: 35-58.
7. Cole J, Sumnall H, Grob CS. 2002. Sorted: ecstasy facts and fiction. Psychol 15: 464-467.
8. Collette F, Hogge M, Salmon E, Van der Linden M. 2006. Exploration of the neural substrates of executive functioning by functional neuroimaging. Neuroscience 139: 209-221.
9. Croft RJ, Mackay AJ, Mills ATD, Gruzelier JGH. 2001. The relative contributions of ecstasy and cannabis to cognitive impairment. Psychopharmacology 153: 373-379.
10. Dafters RI, Hoshi R, Talbot AC. 2004. Contribution of cannabis and MDMA ("ecstasy") to cognitive changes in long term polydrug users. Psychopharmacology 173: 405-410.
11. Fisk JE. 2003. Age differences in associative learning: the role of working memory and executive processes. Proc Br Psychol Soc 11: 270.
12. Fisk JE, Montgomery C, Murphy P, Wareing M. 2004. Evidence of executive deficits among users of MDMA (Ecstasy). Br J Psychol 95: 457-466.
13. Fisk JE, Montgomery C, Wareing M, Murphy P. 2005. Reasoning deficits in ecstasy (MDMA) polydrug users. Psychopharmacology 181(3): 550-559.
14. Fisk JE, Sharp CA. 2002. Syllogistic reasoning and cognitive ageing. Q J Exp Psychol 55A: 1273-1293.
15. Fisk JE, Sharp CA. 2004. Age-related impairment in executive functioning: updating, inhibition, shifting, and access. J Clin Exp Neuropsychol 26: 874-890.
16. Fisk JE, Warr P. 1996. Age and Working memory: the role of perceptual speed, the Central Executive and the phonological loop. Psychol Aging 11: 316-323.
17. Fox HC, McLean A, Turner JJD, Parrott AC, Rogers R, Sahakian BJ. 2002. Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users. Psychopharmacology 162: 203-214.
18. Gillberg M, Kecklund G, Akerstedt T. 1994. Relations between performance and subjective ratings of sleepiness during a night awake. Sleep 17: 236-241.
19. Gillberg M, Kecklund G, Axelsson J, Akerstedt T. 1996. The effects of a short daytime nap after restricted night sleep. Sleep 19: 570-575.
20. Gouzoulis E, Steiger A. Ensslin M, Kovar A, Hermle L. 1992. Sleep EEG effects of 3,4-methylenedioxyethamphetamine (MDE; "eve") in healthy volunteers. Biol Psychiatry 32: 1108-1117.
21. Harma M, Sallinen M, Ranta R, Mutanen P, Muller K. 2002. The effect of an irregular shift system on sleepiness at work in train drivers and railway traffic controllers. J Sleep Res 11: 141-151.
22. Harrison Y, Horne JA. 1999. One night of sleep loss impairs innovative thinking and flexible decision making. Organ Behav Hum Decis Process 78(2): 128-145.
23. Harrison Y, Horne JA. 2000. The impact of sleep deprivation on decision-making: a review. J Exp Psychol Appl 6: 236-249.
24. Huwig-Poppe C, Voderholzer U, Backhaus J, Riemann D, Konig A, Hohagen F. 1999. The tryptophan depletion test - impact on sleep in healthy subjects and patients with obsessive-compulsive disorder. Adv Exp Med Biol 467: 35-42.
25. Huxster JK, Pirona A, Morgan MJ. 2006. The sub-acute effects of recreational ecstasy (MDMA) use: a controlled study in humans. J Psychopharmacol 20(2): 281-290.
26. Johns MW. 1992. Reliability and factor-analysis of the Epworth Sleepiness Scale. Sleep 15: 376-381.
27. Johns MW. 2000. Sensitivity and specificity of the multiple sleep latency test (MSLT), the maintenance of wakefulness test and the Epworth sleepiness scale: failure of the MSLT as a gold standard. J Sleep Res 9: 5-11.
28. Johns M, Hocking B. 1997. Daytime sleepiness and sleep habits of Australian workers. Sleep 20: 844-849.
29. Kolb B, Whishaw IQ. 1985. Fundamentals of Human Neuropsychology, (2nd edn.). W.H. Freeman and Co.: New York.
30. Lieberman HR, Tharion WJ, Shukitt-Hale B, Speckman KL, Tulley R. 2002. Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Psychopharmacology 164: 250-261.
31. Maquet P. 2001. The role of sleep in learning and memory. Science 294: 1048-1051.
32. Markus CR, Jonkman LM, Lammers JHCM, Deutz NEP, Messer MH, Rigtering N. 2005. Evening intake of alpha-lactalbumin increases plasma tryptophan availability and improves morning alertness and brain measures of attention. Am J Clin Nutr 81: 1026-1033.
33. McCann UD, Eligulashvili V, Ricaurte GA. 2000 3,4-methylenedioxymethamphetamine ("ecstasy")-induced serotonin neurotoxicity: clinical studies. Neuropsychobiology 42: 11-16.
34. Miyake A, Friedman NP, Emerson MJ, Witzki AH, Howerter A, Wager TD. 2000. The unity and diversity of executive functions, and their contributions to complex "frontal lobe" tasks: a latent variable analysis. Cognit Psychol 41(1): 49-100.
35. Montgomery C, Fisk JE, Newcombe R. 2005b. The nature of ecstasy-group related deficits in associative learning. Psychopharmacology 180: 141-149.
36. Montgomery C, Fisk JE, Newcombe R, Murphy PN. 2005a. The differential effects of ecstasy/polydrug use on executive components: shifting, inhibition, updating and access to semantic memory. Psychopharmacology 182: 262-276.
37. Montgomery C, Fisk JE, Newcombe R, Wareing M, Murphy P. 2005c. Syllogistic reasoning performance in MDMA (ecstasy) users. Exp Clin Psychopharmacol 13: 137-145.
38. Montoya AG, Sorrentino R, Lukas SE, Price BH. 2002. Long-term neuropsychiatric consequences of "ecstasy" (MDMA): a review. Harvard Rev Psychiatry 10: 212-220.
39. Morgan MJ. 1998. Recreational use of "ecstasy" (MDMA) is associated with elevated impulsivity. Neuropsychopharmacology 19: 252-264.
40. Morgan MJ. 1999. Memory deficits associated with recreational use of "ecstasy" (MDMA). Psychopharmacology 141: 30-36.
41. Morgan MJ. 2000. Ecstasy (MDMA): a review of its possible persistent psychological effects. Psychopharmacology 152: 230-248.
42. Morris N, Jones DM. 1990. Memory updating in working memory: the role of the central executive. Br J Psychol 81: 111-121.
43. Nilsson JP, Soderstrom M, Karlsson AU, et al. 2005. Less effective executive functioning after one night's sleep deprivation. J Sleep Res 14: 1-6.
44. Otmani S, Roge J, Muzet A. 2005. Sleepiness in professional drivers: effect of age and time of day. Accid Anal Prev 37: 930-937.
45. Parkin AJ, Java RI. 1999. Deterioration of frontal lobe function in normal aging: influences of fluid intelligence versus perceptual speed. Neuropsychology 13: 539-545.
46. Parrott AC, Sisk E, Turner JJD. 2000. Psychobiological problems in heavy "ecstasy" (MDMA) polydrug users. Drug Alcohol Depend 60: 105-110.
47. Parrott AC, Rodgers J, Buchanan T, Ling J, Heffernan T, Scholey AB. 2006. Dancing hot on ecstasy: physical activity and thermal comfort ratings are associated with the memory and other psychobiological problems reported by recreational MDMA users. Hum Psychopharmacol Clin Exp 21: 285-298.
48. Reay JL, Hamilton C, Kennedy DO, Scholey AB. 2006. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. J Psychopharmacol 20: 385-388.
49. Richter S, Marsalek K, Glatz C, Gundel A. 2005. Task-dependent differences in subjective fatigue scores. J Sleep Res 14: 393-400.
50. Rodgers J. 2000. Cognitive performance amongst recreational users of "ecstasy". Psychopharmacology 151: 19-24.
51. Salthouse TA, Babcock RL. 1991. Decomposing adult age differences in working memory. Dev Psychol 27: 763-776.
52. Swann CE, Yelland GW, Redman JR, Rajaratnam SMW. 2006. Chronic partial sleep loss increases the facilitatory role of a masked prime in a word recognition task. J Sleep Res 15: 23-29.
53. Topp L, Hando J, Dillon P, Roche A, Solowij N. 1999. Ecstasy use in Australia: patterns of use and associated harm. Drug Alcohol Depend 55: 105-115.
54. van den Berg J, Neelya G, Nilsson L, Knutssond A, Landstrma U. 2005. Electroencephalography and subjective ratings of sleep deprivation. Sleep Med 6: 231-240.
55. Van der Linden M, Collette F, Salmon E, et al. 1999. The neural correlates of updating information in verbal working memory. Memory 7: 549-560.
56. Vignatelli L, Plazzi G, Barbato A, et al. 2003. Italian version of the Epworth sleepiness scale: external validity. Neurolog Sci 23: 295-300.
57. Violani C, Lucidi F, Robusto E, Devoto A, Zucconi M, Strambi LF. 2003. The assessment of daytime sleep propensity: a comparison between the Epworth Sleepiness Scale and a newly developed resistance to sleepiness scale. Clin Neurophysiol 114: 1027-1033.
58. Voderholzer U, Hornyak M, Thiel B, et al. 1998. Impact of experimentally induced serotonin deficiency by tryptophan depletion on sleep EEG in healthy subjects. Neuropsychopharmacology 18: 112-124.
59. Wareing M, Fisk JE, Murphy PN, Montgomery C. 2004. Visuo-spatial working memory deficits in current and former users of MDMA ('ecstasy'). Hum Psychopharmacol: Clin Exp 20(2): 115-123.
60. Warkentin S, Passant U. 1997. Functional imaging of the frontal lobes in organic dementia: regional cerebral blood flow findings in normals, in patients with frontotemporal dementia, and in patients with Alzheimer's disease, performing a word fluency test. Dement Geriatr Cogn Disord 8: 105-109.